Evidence map›Paper›PMID 26363049›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Class A Scavenger Receptor-Mediated Double-Stranded RNA Internalization Is Independent of Innate Antiviral Signaling and Does Not Require Phosphatidylinositol 3-Kinase Activity.

Srinivas Nellimarla, Kaushal Baid, Yueh-Ming Loo, Michael Gale, Dawn M E Bowdish, Karen L Mossman

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. PepFect14 Signaling and Transfection.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  5. Article
  6. Development of Drugs Based on High-Polymeric Double-Stranded RNA for Antiviral and Antitumor Therapy.Biochemistry (Moscow) Supplement. Series B, Biomedical chemistry · 2019
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Srinivas NellimarlaDepartment of Pathology and Molecular Medicine, McMaster Immunology Research Center, Michael DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada L8S 4K1;
Kaushal BaidDepartment of Pathology and Molecular Medicine, McMaster Immunology Research Center, Michael DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada L8S 4K1;
Yueh-Ming LooDepartment of Immunology, Center for Innate Immunity and Immune Disease, School of Medicine, University of Washington, Seattle, WA 98109; and.
Michael GaleDepartment of Immunology, Center for Innate Immunity and Immune Disease, School of Medicine, University of Washington, Seattle, WA 98109; and.
Dawn M E BowdishDepartment of Pathology and Molecular Medicine, McMaster Immunology Research Center, Michael DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada L8S 4K1;
Karen L MossmanDepartment of Pathology and Molecular Medicine, McMaster Immunology Research Center, Michael DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada L8S 4K1; Department of Biochemistry and Biomedical Sciences, McMaster Immunology Research Center, Michael DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada L8S 4K1 mossk@mcmaster.ca.
McMaster University · CAUniversity of Washington · US

Funding

Innate Immune Control of West Nile VirusR01AI104002 · NIAID · UNIVERSITY OF WASHINGTON · PI DIAMOND, MICHAEL S, GALE, MICHAEL · 2013 to 2017
$3.7M
Canadian Institutes of Health Research MOP-123383NIAID NIH HHS R01 AI104002
6 · The paper itself

Abstract

dsRNA is a potent trigger of innate immune signaling, eliciting effects within virally infected cells and after release from dying cells. Given its inherent stability, extracellular dsRNA induces both local and systemic effects. Although the class A scavenger receptors (SR-As) mediate dsRNA entry, it is unknown whether they contribute to signaling beyond ligand internalization. In this study, we investigated whether SR-As contribute to innate immune signaling independent of the classic TLR and retinoic acid-inducible gene-I-like receptor (RLR) pathways. We generated a stable A549 human epithelial cell line with inducible expression of the hepatitis C virus protease NS3/4A, which efficiently cleaves TRIF and IFN-β promoter stimulator 1, adaptors for TLR3 and the RLRs, respectively. Cells expressing NS3/4A and TLR3/MyD88/IFN-β promoter stimulator 1(-/-) mouse embryonic fibroblasts completely lacked antiviral activity to extracellular dsRNA relative to control cells, suggesting that SR-As do not possess signaling capacity independent of TLR3 or the RLRs. Previous studies implicated PI3K signaling in SR-A-mediated activities and in downstream production of type I IFN. We found that SR-A-mediated dsRNA internalization occurs independent of PI3K activation, whereas downstream signaling leading to IFN production was partially dependent on PI3K activity. Overall, these findings suggest that SR-A-mediated dsRNA internalization is independent of innate antiviral signaling.

Indexed as

Immunity, InnateAdaptor Proteins, Vesicular TransportAnimalsCell LineDEAD-box RNA HelicasesHepacivirusHumansMiceMice, KnockoutMyeloid Differentiation Factor 88Nucleoside-TriphosphatasePhosphatidylinositol 3-KinasesRNA, Double-StrandedRNA, ViralScavenger Receptors, Class ASerine EndopeptidasesAdaptor Proteins, Vesicular TransportDEAD-box RNA HelicasesMyd88 protein, mouseMyeloid Differentiation Factor 88NS3 protein, hepatitis C virusNS4A protein, flavivirusNucleoside-TriphosphatasePhosphatidylinositol 3-KinasesRNA, Double-StrandedRNA, ViralScavenger Receptors, Class ASerine EndopeptidasesTicam1 protein, mouseTLR3 protein, mouseToll-Like Receptor 3Viral Nonstructural ProteinsViral Proteases

Identifiers

PMID26363049
PMCPMC4904834
OpenAlexW2190822649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.